 |
answer text |
<p>The Department is doing everything appropriate to prepare for leaving the European
Union. We want to reassure patients that our plans should ensure the uninterrupted
supply of medicines and medical products once we have left the EU.</p><p>The Government
has published its reasonable worst-case planning assumptions for a no-deal EU exit
scenario as of 2 August 2019. These assumptions are available at the following link:</p><p><a
href="https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/831199/20190802_Latest_Yellowhammer_Planning_assumptions_CDL.pdf"
target="_blank">https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/831199/20190802_Latest_Yellowhammer_Planning_assumptions_CDL.pdf</a></p><p>
</p><p>My Department, as part of our EU exit preparations, is implementing a multi-layered
approach to mitigate potential disruption to supply on the Channel short straits routes,
which consists of stockpiling where possible, securing freight capacity, changing
or clarifying regulatory requirements, procuring additional warehousing, working closely
with industry to improve trader readiness and putting in place the National Supply
Disruption Response to manage potential shortages. Further details can be found at
the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans"
target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a>.</p><p>
</p>
|
|
